ENO1 and neoplasm: Interestingly, Cappello and colleagues demonstrated that autologous DC, which were pulsed with recombinant ENO-1, increased T-cell proliferation and enhanced the production of interferon-γ (IFN-γ) [4], a well-described anti-tumor agent [81].